Alar Pharmaceuticals Inc. (TPEX:6785)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
170.00
+2.00 (1.19%)
Apr 20, 2026, 1:08 PM CST
Market Cap11.22B +15.9%
Revenue (ttm)2.75M -52.7%
Net Income-79.68M
EPS-1.19
Shares Out66.80M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.06%)
Ex-Dividend DateJun 10, 2025
Volume2,000
Average Volume123,699
Open168.00
Previous Close168.00
Day's Range168.00 - 174.00
52-Week Range112.50 - 317.00
Beta0.35
RSI41.29
Earnings DateMay 8, 2026

About Alar Pharmaceuticals

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson’s disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan. [Read more]

Sector Healthcare
Founded 2016
Employees 27
Stock Exchange Taipei Exchange
Ticker Symbol 6785
Full Company Profile

Financial Performance

Financial Statements